Market Overview:
The global asthma and COPD devices market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of asthma and COPD, rising awareness about these diseases, and technological advancements in asthma and COPD devices. The inhaler segment is expected to dominate the global asthma and COPD devices market during the forecast period. This segment is projected to grow at a CAGR of 6% from 2018 to 2030. The nebulizer segment is projected to grow at a CAGR of 5% from 2018to 2030.
Product Definition:
Asthma and COPD Devices refer to a variety of medical devices that are used to help treat asthma and chronic obstructive pulmonary disease (COPD). These devices can include things like inhalers, nebulizers, and spacer tanks. They are important because they can help improve the quality of life for people with these conditions by helping them to breathe more easily.
Inhaler:
An inhaler is a device used to deliver medication by breathing. It consists of an asthma inhalation medicine and a compressor that provides the pressure necessary for inhaling the drug. The most common types of inhalers are nebulizers, dry powder, liquid, and pressurized metered-dose inhalers (pMDIs).
Nebulizer:
Nebulizer is a device that aids in the delivery of respiratory medications. It consists of a cup, which holds the liquid medication and a fan, which helps in inhaling and expelling the drug vapor into the patient's lungs. The nebulizers available today are portable; they can be carried around by attaching them to belts or harnesses. Some patients find it easier to use them at home as compared to hospitals where they have to wait for their turn for an inhaler.
Application Insights:
The others segment held the largest share of the global asthma and COPD devices market in 2017. This application category includes clinics, home healthcare, and other locations. The growing prevalence of chronic diseases such as heart diseases, respiratory infections, arthritis and diabetes mellitus is expected to drive demand for inhalers in this segment over the forecast period.
Online stores are anticipated to be one of the fastest-growing segments due to increasing consumer preference for online purchasing owing to various benefits including convenience and ease of use along with competitive prices that retailers can offer. Moreover, manufacturers are also offering free shipping along with purchases above a certain price which further encourages consumers towards online purchasing. Increasing usage rates of nebulizers across hospitals coupled with rising awareness regarding COPD is expected to fuel demand from medical machinery sales centers over the forecast period thereby driving overall market growth during this period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and rising prevalence of asthma and COPD are some factors responsible for its large share. In addition, increasing awareness about asthma management is also expected to drive the demand for devices over the forecast period. For instance, Asthma Canada distributes educational material such as fact sheets and booklets that provide detailed information regarding treatment options to patients across Canada.
Growth Factors:
- Increasing prevalence of asthma and COPD
- Rising awareness about the benefits of asthma and COPD devices
- Technological advancements in asthma and COPD devices
- Growing demand for home-based respiratory care therapies
- Increasing number of product approvals by regulatory authorities
Scope Of The Report
Report Attributes
Report Details
Report Title
Asthma and COPD Devices Market Research Report
By Type
Inhaler, Nebulizer
By Application
Hospital, Online Store, Medical Machinery Sales Center, Other
By Companies
AstraZeneca, Boehringer Ingelheim, Drive DeVilbiss Healthcare, GF Health Products, Glaxosmithcline, Invacare, Merck, Omron Healthcare, PARI Pharma, Philips Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Asthma and COPD Devices Market Report Segments:
The global Asthma and COPD Devices market is segmented on the basis of:
Types
Inhaler, Nebulizer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Online Store, Medical Machinery Sales Center, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Boehringer Ingelheim
- Drive DeVilbiss Healthcare
- GF Health Products
- Glaxosmithcline
- Invacare
- Merck
- Omron Healthcare
- PARI Pharma
- Philips Healthcare
Highlights of The Asthma and COPD Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inhaler
- Nebulizer
- By Application:
- Hospital
- Online Store
- Medical Machinery Sales Center
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Asthma and COPD Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Asthma and COPD devices are medical devices that help people with asthma or COPD breathe easier. These devices can include inhalers, nebulizers, masks, and other equipment.
Some of the major players in the asthma and copd devices market are AstraZeneca, Boehringer Ingelheim, Drive DeVilbiss Healthcare, GF Health Products, Glaxosmithcline, Invacare, Merck, Omron Healthcare, PARI Pharma, Philips Healthcare.
The asthma and copd devices market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Asthma and COPD Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Asthma and COPD Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Asthma and COPD Devices Market - Supply Chain
4.5. Global Asthma and COPD Devices Market Forecast
4.5.1. Asthma and COPD Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Asthma and COPD Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Asthma and COPD Devices Market Absolute $ Opportunity
5. Global Asthma and COPD Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Asthma and COPD Devices Market Size and Volume Forecast by Type
5.3.1. Inhaler
5.3.2. Nebulizer
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Asthma and COPD Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Asthma and COPD Devices Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Online Store
6.3.3. Medical Machinery Sales Center
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Asthma and COPD Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Asthma and COPD Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Asthma and COPD Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Asthma and COPD Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Asthma and COPD Devices Demand Share Forecast, 2019-2026
9. North America Asthma and COPD Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Asthma and COPD Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Asthma and COPD Devices Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Online Store
9.4.3. Medical Machinery Sales Center
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Asthma and COPD Devices Market Size and Volume Forecast by Type
9.7.1. Inhaler
9.7.2. Nebulizer
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Asthma and COPD Devices Demand Share Forecast, 2019-2026
10. Latin America Asthma and COPD Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Asthma and COPD Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Asthma and COPD Devices Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Online Store
10.4.3. Medical Machinery Sales Center
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Asthma and COPD Devices Market Size and Volume Forecast by Type
10.7.1. Inhaler
10.7.2. Nebulizer
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Asthma and COPD Devices Demand Share Forecast, 2019-2026
11. Europe Asthma and COPD Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Asthma and COPD Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Asthma and COPD Devices Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Online Store
11.4.3. Medical Machinery Sales Center
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Asthma and COPD Devices Market Size and Volume Forecast by Type
11.7.1. Inhaler
11.7.2. Nebulizer
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Asthma and COPD Devices Demand Share, 2019-2026
12. Asia Pacific Asthma and COPD Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Asthma and COPD Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Asthma and COPD Devices Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Online Store
12.4.3. Medical Machinery Sales Center
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Asthma and COPD Devices Market Size and Volume Forecast by Type
12.7.1. Inhaler
12.7.2. Nebulizer
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Asthma and COPD Devices Demand Share, 2019-2026
13. Middle East & Africa Asthma and COPD Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Asthma and COPD Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Asthma and COPD Devices Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Online Store
13.4.3. Medical Machinery Sales Center
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Asthma and COPD Devices Market Size and Volume Forecast by Type
13.7.1. Inhaler
13.7.2. Nebulizer
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Asthma and COPD Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Asthma and COPD Devices Market: Market Share Analysis
14.2. Asthma and COPD Devices Distributors and Customers
14.3. Asthma and COPD Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AstraZeneca
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boehringer Ingelheim
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Drive DeVilbiss Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GF Health Products
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Glaxosmithcline
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Invacare
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Merck
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Omron Healthcare
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. PARI Pharma
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Philips Healthcare
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook